Perspective
Election Verdict: Pharma Needs a New Prescription
November 14, 2016
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD
Research
All Research Featured Research
Perspective
How to Get Rid of Surprise Medical Bills
October 18, 2016
Featured Experts: Paul Ginsburg, PhD, Steven M. Lieberman, MPhil, MA
Evidence Base
Encouraging Integrative, Non-Opioid Approaches To Pain: A Policy Agenda
October 4, 2016
Featured Experts: Jason Doctor, PhD
Perspective
To Prevent Another EpiPen Controversy, the Government Should Step In
August 29, 2016
Featured Experts: Dana Goldman, PhD
Perspective
Clinton and Trump are Both Wrong about Medicare’s Ability to Negotiate Drug Prices
August 13, 2016
Featured Experts: Geoffrey Joyce, PhD, Neeraj Sood, PhD
Perspective
Affordable Care Act Premiums are Lower Than You Think
July 25, 2016
Featured Experts: Paul Ginsburg, PhD
Evidence Base
Health Affairs Study On Hospital Profitability Gives Us Some Important Factors To Watch Going Forward
June 23, 2016
Featured Experts: Glenn Melnick, PhD
Evidence Base
Making Better Antibiotic Prescribing Decisions
June 3, 2016
Featured Experts: Jason Doctor, PhD
Brookings Schaeffer on Health Policy
CMMI’s New Comprehensive Primary Care Plus: Its Promise And Missed Opportunities
May 31, 2016
Featured Experts: Paul Ginsburg, PhD
Evidence Base
Why Do So Many Doctors Practice Defensive Medicine? Maybe Because it Works
May 16, 2016
Featured Experts: Seth Seabury, PhD
Brookings Schaeffer on Health Policy
Physician Payment in Medicare is Changing: Three Highlights in the MACRA Proposed Rule That Providers Need to Know
May 4, 2016
Featured Experts: Paul Ginsburg, PhD
Perspective
How to Stop Overprescribing Antibiotics
March 25, 2016
Featured Experts: Jason Doctor, PhD
Evidence Base
What the Candidates Don’t Get About Drug Prices
March 18, 2016
Featured Experts: Dana Goldman, PhD
Evidence Base
A Medication Lock-In Program May Not Be the Easy Solution to the Opioid Abuse Epidemic That Congress Thinks It Is
January 12, 2016
Featured Experts: Sarah Axeen, PhD
Perspective
Drop Medicaid ‘Best Price’ Rule Drug Rules in Favor of Value-Based Strategies
November 19, 2015
Featured Experts: Dana Goldman, PhD
Perspective
Moving Beyond Price-Per-Dose In The Pharmaceutical Industry
September 15, 2015
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD
